Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | President | March 17, 2026 | March 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date March 17, 2026 · Filed March 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,000 |
Ending reported balance
After 2026-03-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-17 · Exercise / conversion · Acquired 31,707 · Balance 46,707 Row 2 · 2026-03-17 · Sale · Disposed 31,707 · Balance 15,000 F1: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $451.36 to $460.288. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $138.87 · Expires 2027-08-15 | Direct | 0 |
Reported balance
After 2026-03-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-03-17 · Exercise / conversion · Disposed 31,707 · Balance 0 F2: The option vested in full on February 15, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $451.36 to $460.288. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F2: The option vested in full on February 15, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2020 Filed Mar 3, 2020 21:50 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 41,801 | $0.00 Strike: $107.93 | $0.00 |
DisclosureSEC source: 0001567619-20-005465 · doc1.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,801 Underlying: Common Stock · 41,801 shares Expires 2026-02-28 F1 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| February 28, 2020 Filed Mar 3, 2020 21:50 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantCommon Stock | 6,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-005465 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,382 Read SEC document |
| December 20, 2019 Filed Dec 23, 2019 21:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 16,948 | $84.00 | $1,423,632.00 |
DisclosureSEC source: 0000899243-19-029945 · doc4.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2019. Read SEC document |
| December 19, 2019 Filed Dec 23, 2019 21:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 14,400 | $82.00 | $1,180,800.00 |
DisclosureSEC source: 0000899243-19-029945 · doc4.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,948 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2019. Read SEC document |
| October 15, 2019 Filed Oct 16, 2019 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 9,600 | $80.00 | $768,000.00 |
DisclosureSEC source: 0001567619-19-019630 · doc1.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,348 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2019. Read SEC document |
| October 14, 2019 Filed Oct 16, 2019 20:17 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,200 | $78.03 | $561,816.00 |
DisclosureSEC source: 0001567619-19-019630 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,948 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 21, 2019. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $78.00 to $78.96. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 05, 2019 Filed Aug 7, 2019 20:30 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $90.65 | $0.00 |
DisclosureSEC source: 0001567619-19-015941 · doc1.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2024-08-05 F1 · derivative.exercise_date: The option vests immediately upon issuance. Read SEC document |
| April 05, 2019 Filed Apr 9, 2019 20:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 48,148 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-19-008609 · doc1.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,148 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option was granted on July 7, 2014 and vested in four annual installments of approximately 25% on each grant date anniversary. Read SEC document |
| April 05, 2019 Filed Apr 9, 2019 20:10 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 48,148 | $14.41 | $693,812.68 |
DisclosureSEC source: 0001567619-19-008609 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,148 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:28 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 25,037 | $60.00 | $1,502,220.00 |
DisclosureSEC source: 0001567619-19-008163 · doc1.xml · nonDerivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2018. Read SEC document |
| March 29, 2019 Filed Apr 2, 2019 20:28 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 12,000 | $58.20 | $698,400.00 |
DisclosureSEC source: 0001567619-19-008163 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,037 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2018. F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 1, 2018. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $57.62 to $59.02. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| September 28, 2018 Filed Oct 1, 2018 20:41 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | OtherCommon Stock | 37,037 | $59.91 | $2,218,886.67 |
DisclosureSEC source: 0001567619-18-003367 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,037 F1 · kind: Represents the receipt of MEDP shares in an in-kind distribution by Medpace Investors, LLC ("MPI") to the Reporting Person in exchange for the Reporting Person's Incentive Units of MPI. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 23:29 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 7,407 | $60.15 | $445,531.05 |
DisclosureSEC source: 0000899243-18-021485 · doc4.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.15 to $60.28 per share. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 21:03 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $32.05 | $0.00 |
DisclosureSEC source: 0001140361-18-011629 · doc1.xml · derivative · entry 2 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2025-02-28 F2 · derivative.exercise_date: The option vests on February 28, 2022, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
| June 30, 2017 Filed Mar 2, 2018 21:03 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantCommon Stock | 7,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-011629 · doc1.xml · nonDerivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,407 F1 · price: Shares acquired by an in-kind exchange of Issuer shares for investment units of Medpace Investors, LLC originally acquired by the Reporting Person upon exercise of Issuer options. The options, once exercised, were immediately exchanged for investment units in Medpace Investors, LLC as required by the Medpace Holdings, Inc. 2014 Equity Incentive Plan. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 18:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | GrantEMPLOYEE STOCK OPTION (RIGHT TO BUY) · Derivative | 20,000 | $0.00 Strike: $28.32 | $0.00 |
DisclosureSEC source: 0001209191-17-021296 · doc4.xml · derivative · entry 1 GEIGER JESSE J · CIK 0001677399 · CFO & COO, Lab Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: COMMON STOCK · 20,000 shares Expires 2024-03-15 F1 · derivative.exercise_date: The option vests on March 15, 2021, subject to the Reporting Person's continued employment with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.